Skip to main content

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

Agency: Defense Health Agency Contracting Activity - DHACA

Assistance Listings
  • 12.420 -- Military Medical Research and Development

Open opportunityLast Updated: Sep 3, 2026

Important dates

  • Closing: November 18, 2026

Award details

  • Expected project funding: $10,600,000
  • Expected awards: 6

Award min.

Not specified

Award max.

Not specified

  • Funding opportunity number:HT942526BCRPBTA122
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Grant
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Science technology and other research and development
  • Category Explanation:Not specified

History

  • Posted date: September 3, 2026
  • Archive date: December 18, 2026
  • Version: 1

View version history on Grants.gov

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2.


Distinctive Features:


* This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science Studies option. With compelling justification, population science studies may request higher levels of funding and an additional year in the period of performance.


* This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Eligibility

Miscellaneous

  • Unrestricted

Additional information on eligibility

Not specified

Documents

File nameDescriptionLast updated
HT942526BCRPBTA122_GG.pdf
FY26 BCRP BTA122 Program Announcement
Sep 3, 2026 12:41 PM UTC

Agency contact information

Email: help@eBRAP.org

eBRAP Help Desk

eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov